Evolus, Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Evolus, Inc (EOLS) current stock price?
As of the latest data, Evolus, Inc stock price is $6.39, with a previous close of $6.61. Evolus, Inc lost -$0.22 in the last trading session, representing a -3.33% loss.
What is Evolus, Inc (EOLS) current market capitalization?
Evolus, Inc market cap is approximately 420.81 million.
What is Evolus, Inc (EOLS) Earnings Per Share (EPS)?
The trailing EPS is -$0.68, and the forward EPS is $0.24.
What is Evolus, Inc (EOLS) EBITDA?
Evolus, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.75 million.
Does Evolus, Inc (EOLS) pay dividends?
No. Evolus, Inc does not pay a dividend.
How did Evolus, Inc (EOLS) perform in its most recent earnings report?
In the last report (March 31, 2026), Evolus, Inc posted an EPS surprise of 58.33% and a revenue surprise of 1.34%.
When is Evolus, Inc (EOLS) next earnings report?
Evolus, Inc is expected to release its next earnings report on June 30, 2026.
What is Evolus, Inc (EOLS) beta (volatility) score?
Evolus, Inc has a beta of 1.334, suggesting it is more volatile than the market.
